Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/16086
Title: A comparative analysis between antibiotic- and nonantibiotic-associated delayed cutaneous adverse drug reactions
Authors: Trubiano, Jason A;Aung, Ar Kar;Nguyen, Mary;Fehily, Sasha R;Graudins, Linda;Cleland, Heather;Padiglione, Alex;Peleg, Anton Y
Issue Date: 7-Jun-2016
EDate: 2016-06-07
Citation: The Journal of Allergy and Clinical Immunology: In Practice 2016; online first: 7 June
Abstract: BACKGROUND:The difference in clinical presentation, causality assessments, and outcomes of patients with delayed antibiotic-associated cutaneous adverse drug reactions (AA-cADR) and nonantibiotic-associated (NA)-cADR is ill defined. OBJECTIVE: We examined the etiology of AA-cADR, with regard to the type of antibiotic exposure, allergy labeling, and patient outcomes, in comparison with NA-cADR. METHODS: A retrospective observational inpatient cohort study of cADR was performed from January 2004 to August 2014. Patients were divided into AA-cADR and NA-cADR groups for analysis. cADR was defined as erythema multiforme, fixed drug eruption, acute generalized erythematous pustulosis, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-associated linear IgA disease, Stevens-Johnson syndrome, and toxic epidermal necrolysis. RESULTS: Of the 84 patients with cADR, 48% were AA-cADR. Male sex (60% vs 32%, P = .004), median length of stay (14.5 vs 11 days, P = .05), median Charlson comorbidity index (3 vs 1, P = .03), and inpatient mortality (20% vs 5%, P = .04) were higher in AA-cADR compared with NA-cADR. The median drug latency was lower in AA-cADR (6 vs 20 days, P = .001). Sulfonamide antibiotics and glycopeptides were implicated in 20% of AA-cADR. DRESS was more frequently reported in AA-cADR. After cADR diagnosis, further antibiotic therapy was administered in 64% of patients, higher in AA-cADR (75%, 30 of 40) compared with NA-cADR (55%, 24 of 44) (P = .06). Fluoroquinolones (53% vs 21%, P = .02), glycopeptides (vancomycin and teicoplanin; 70% vs 38%, P = .05), and carbapenems (33% vs 13%, P = .11) were used more commonly in AA-cADR. CONCLUSIONS: Antibiotics were the cause of cADR requiring hospital admission in 48% of episodes, and were associated with longer length of stay, higher age-adjusted Charlson comorbidity index, shorter drug latency, and mortality. In AA-cADR, glycopeptide and sulfonamide antibiotic exposure predominated.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16086
DOI: 10.1016/j.jaip.2016.04.026
PubMed URL: http://www.ncbi.nlm.nih.gov/pubmed/27283055
Type: Journal Article
Subjects: Allergy
Drug reactions
Steven-johnson syndrome
toxic epidermal necrolysis
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.